Publications

Analysis of Autonomic Outcomes in Apollo, a Phase Iii Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis (Vol 264, Pg 703, 2020)

AuthID
P-00R-TG8

Author(s)

Gonzalez Duarte, A

Berk, JL

Quan, DN

Mauermann, ML

Schmidt, HH

Polydefkis, M

Waddington Cruz, M

Ueda, M

Conceicao, IM

Kristen, AV

Coelho, T

Cauquil, CA

Tard, C

Merkel, M

Aldinc, E

Chen, JH

Sweetser, MT

Wang, JJ

Adams, D

Document Type

Correction

Year published

2020

Published

in JOURNAL OF NEUROLOGY, ISSN: 0340-5354

Volume: 267, Issue: 3, Pages: 713-714 (2)

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1007/s00415-020-09715-5

Wos: WOS:000515353700017

Source Identifiers

ISSN: 0340-5354

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Analysis of Autonomic Outcomes in Apollo, a Phase Iii Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis (Vol 264, Pg 703, 2020)

Useful Links

Get Help

Federated Authentication (Click on the image)

Analysis of Autonomic Outcomes in Apollo, a Phase Iii Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis (Vol 264, Pg 703, 2020)

Useful Links

Get Help